Sequential Treatment With Pazopanib (Pazo) Followed By Nivolumab (Nivo) In Patients With Advanced Or Metastatic Renal Cell Carcinoma (Mrcc): Third Interim Results Of The Non-Interventional Study Pazoreal.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 2|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要